Abstract:OBJECTIVES:With the in-depth study of complement dysregulation, glomerulonephritis with dominant C3 has received increasing attention, with a variety of pathologic types and large differences in symptoms and prognosis between pathologic types. This study analyzes the clinical, pathological, and prognostic characteristics of different pathological types of glomerulonephritis with dominant C3, aiming to avoid misdiagnosis and missed diagnoses. METHODS:The clinical, pathological, and follow-up data of 52 patients diagnosed as glomerulonephritis with dominant C3 by renal biopsy from June 2013 to October 2022 were retrospectively analyzed. According to the clinical feature and results of pathology, 15 patients with post-infectious glomerulonephritis (PIGN) and 37 patients with of non-infectious glomerulonephritis (N-PIGN) were classified. N-PIGN subgroup analysis was performed, and 16 patients were assigned into a C3-alone-deposition group and 21 in a C3-dominant-deposition group, or 27 in a C3 glomerulopathy (C3G) group and 10 in a non-C3 nephropathy (N-C3G) group. RESULTS:The PIGN group had lower creatinine values (84.60 μmol/L vs179.62 μmol/L, P=0.001), lower complement C3 values (0.36 g/L vs0.74 g/L, P<0.001) at biopsy, and less severe pathological chronic lesions compared with the N-PIGN group. In the N-PIGN subgroup analysis, the C3-dominant-deposition group had higher creatinine values (235.30 μmol/L vs106.70 μmol/L, P=0.004) and higher 24-hour urine protein values (4 025.62 mg vs1 981.11 mg, P=0.037) than the C3-alone-deposition group. The prognosis of kidney in the PIGN group (P=0.049), the C3-alone-deposition group (P=0.017), and the C3G group (P=0.018) was better than that in the N-PIGN group, the C3-dominant-deposition group, and the N-C3G group, respectively. CONCLUSIONS:Glomerulonephritis with dominant C3 covers a variety of pathological types, and PIGN needs to be excluded before diagnosing C3G because of considerable overlap with atypical PIGN and C3G; in addition, the deposition of C1q complement under fluorescence microscope may indicate poor renal prognosis, and relevant diagnosis, treatment, and follow-up should be strengthened.

Advances in the treatment of C3 glomerulopathy

Diagnosis and Treatment with Integrated Chinese and Western Medicine for C3 Glomerulonephritis

C3 Glomerulonephritis:Clinicopathologic Analysis of 17 Cases

C3 glomerulopathy — understanding a rare complement-driven renal disease

Clinicopathologic features of patients with C3 glomerulopathy

C3 glomerulonephritis associated with monoclonal gammopathy: a retrospective case series study from a single institute in China

Diagnosis and treatment of C1 q nephropathy

Pay attention to the diagnosis and differential diagnosis of C3 glomerulopathy

C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic

Pathogenesis and Treatment Options

C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation

Capillary Deposition of Complement C4d and C3d in Chinese Renal Allograft Biopsies.

Clinical and pathological features of 52 patients with glomerulonephritis with dominant C3.

The Difficulties of Treating Complement-3–Mediated Glomerulopathy

Complement Terminal Pathway Activation and Intrarenal Immune Response in C3 Glomerulopathy

Clinical value of complements detection in C3 glomerulopathy

[Complement System Regulation and C3 Glomerulopathy].

A Retrospective Analysis of Clinicopathology and Plasma Complement Activation in C3 Glomerulonephritis

Characteristics of pediatric C3 glomerulopathy with decreased factor H in 3 cases

Crescentic Acute Glomerulonephritis with Isolated C3 Deposition: A Case Report and Review of Literature

Severe Glomerular C3 Deposition Indicates Severe Renal Lesions and a Poor Prognosis in Patients with Immunoglobulin A Nephropathy